Clinical Research Fellowship in GI Cancer
Applications for the Merck-AGITG Clinical Research Fellowship in GI Cancer are now closed.
This prestigious one-year Fellowship at the Royal Marsden Hospital, London, is valued at £65,500 GBP (AUD$123,000) which includes employer pension and tax contributions, per NHS salary scale AUD$150,000. The Fellowship provides early career researchers with an opportunity to work in the busiest GI clinic in the UK and to assist in the development of collaborative links between the AGITG and UK research groups.
A major objective of the activity is to foster career development by encouraging the beneficial experience of a different research environment.
Dr Lorraine Chantrill, Chair of the AGITG, says, “We are proud to be able to continue this partnership with Merck into the second year of the Merck-AGITG Clinical Research Fellowship. This is a rare opportunity for the Fellow to train with experts in one of the UK’s most influential and busiest GI clinics, strengthening the AGITG’s links with UK researchers. Fostering international collaboration in this way is key to changing outcomes for GI cancer patients.”
This Fellowship aims to further the successful candidate’s study in London and bring those learnings back to clinical practice in Australia or New Zealand. It also provides an avenue for ongoing tri-national collaboration.
This Fellowship opportunity follows on from the first Fellowship which was undertaken by Dr David Lau who upon return from the UK recently, was appointed Deputy Chair of the AGITG International Development Committee.
Merck has been involved in providing oncology medicines in Australia for many years and we greatly value the work being undertaken by the Australasian Gastro-Intestinal Trials Group to build knowledge and ensure Australia and New Zealand stay at the forefront of treating patients with gastrointestinal diseases.